Anwar Alhaq
Papers
1
Total Citations
9
H-Index
1
About
Dr. Anwar Alhaq has made significant contributions to the field of hemostasis and thrombosis, with a particular focus on the diagnostic challenges of von Willebrand Disease (VWD) and hemophilia. His most cited work, "Evaluation of an automated screening assay for von Willebrand Disease Type 2N" (2002, 9 citations), addresses a critical diagnostic gap: distinguishing VWD type 2N (Normandy) from mild hemophilia A. This distinction is vital for accurate genetic counseling and treatment, as both conditions present with low factor VIII levels but arise from different genetic defects. Dr. Alhaq’s research advanced the automation of the factor VIII binding activity assay for von Willebrand factor, improving screening efficiency in clinical laboratories. His work has been instrumental in refining diagnostic protocols for families affected by apparent mild hemophilia A, ensuring that patients receive appropriate management. While his citation count reflects a focused, niche impact, his contributions have directly influenced laboratory practice in specialized coagulation centers. Dr. Alhaq’s dedication to improving rare bleeding disorder diagnostics underscores his role as a meticulous researcher committed to translating molecular insights into practical clinical tools.
Research Focus
Key Achievements
Top Papers
- 1